Pharma patient affordability revenue grew 110% year-over-year to $16.6 million. Losing 113 plasma centers reduces fourth-quarter revenue by $1.5 million.
| Quartal / Datum | EPS (USD) | Schätzung (USD) | Abweichung |
|---|
| Quartal / Datum | Umsatz (Mio USD) | Schätzung (Mio USD) | Abweichung |
|---|